Search Results 51-60 of 14783 for Proto-oncogene
Latest stories · Mayo Clinic study suggests patients with lung cancer be screened for MET oncogene featured image · Newly discovered genetic variants in a single ...
The purpose of this study is to study the handling of ovarian tissue, cryopreservation technology, and oocyte maturation for female pediatric cancer ...
The neu (c-erbB-2) proto-oncogene encodes a tyrosine kinase receptor that is overexpressed in 20 to 30% of human breast tumors. Herein, cyclin D1 protein ...
Resources. Dr. Kannan recommends exploring these professional and patient resources related to stem cells, cancer biology and breast cancer.
This pilot clinical trial studies how well buparlisib works in treating patients with non-Hodgkin lymphoma that has returned or does not respond to treatment.
Collection of tissue and blood from patients with residual disease after neoadjuvant systemic therapy for breast cancer. We hope to use these samples to ...
Participation eligibility · Histologically confirmed diagnosis of melanoma. · Presence of B-RAF proto-oncogene, V600 mutant (BRAFV600) mutation in tumor tissue ...
The Epigenetic Etiology of Human Disease Laboratory at Mayo Clinic is analyzing DNA methylation and histone modifications over the stem cell genome.
About this study. Cells with increased oncogene activity adopt a secretory phenotype. For example, increased levels of c-Src not only inhibit ...
Mayo Clinic's Epigenetic Etiology of Human Disease Lab is studying epigenetics and drug responses with several epigenetic pharmacological studies underway.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Mayo Clinic researchers drive discoveries that improve detection, diagnosis and treatment. Your quick message to them means so much.